-
MJFF Scientist Among Featured Speakers at Neurodegenerative Drug Development Summit
February 5, 2020
… disorders—which include Parkinson’s, Alzheimer’s, ALS, and multiple sclerosis, and others—have many features and … the three-day Neurodegenerative Drug Development Summit. Multiple companies that have received support from MJFF are …
-
Jimmy Choi
… and the PD community. Since then, Jimmy has participated in multiple clinical trials to further research for better … full marathons, one ultra-marathon, six Grand Fondo rides, multiple Spartan Races and countless 5K and 10K runs. To …
-
Wearable Airbag Technology to Mitigate Falls in Individuals with Parkinson’s Disease
… Hypothesis: We expect that a smart, wearable airbag system that can accurately predict falls and quickly inflate … study design involves two steps: (1) improving the airbag system so it can accurately detect falls in people with Parkinson’s and (2) testing whether the system reduces injuries caused by falling. A group of 25 …
-
Development and Optimization of a Regulatable Gene Switch for Gene Therapies of Parkinson’s Disease
… Parkinson’s disease. By using a virus or other DNA delivery system to permanently insert a new gene into critical … has a novel gene regulation technology, the RheoSwitch (R) system, which allows both the level (dose) and timing … “Activator Drug” in pill form. RheoGene’s RheoSwitch (R) system and Activator Drug can be used with any gene and any …
-
Alpha-synuclein May Be Responsible for the Link Between Parkinson's Disease and Melanoma
… of alpha-synuclein may interact with dopaminergic system and may inhibit synthesis of melanin, supporting our …
-
Virtual Reality to Reduce Fall Risk in Patients with Parkinson’s Disease
… study is to evaluate the potential of training with a VR system to improve gait and walking stability. We hypothesis … through problem solving, while promoting the performance of multiple repetitions of movement. We developed an approach …